Evidence map›Paper›PMID 37920236›Full record

ArticleMolecular therapy. Methods & clinical development2023

Prostaglandin E2 as transduction enhancer affects competitive engraftment of human hematopoietic stem and progenitor cells.

Valentina Poletti, Annita Montepeloso, Danilo Pellin, Alessandra Biffi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular therapy. Methods & clinical development, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Biomanufacturing in gene and cell therapy.Molecular therapy. Methods & clinical development · 2024
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Valentina PolettiDivision of Pediatric Hematology, Oncology and Stem Cell Transplantation, Woman's and Child Health Department, University of Padova, 35128 Padova, Italy.
Annita MontepelosoGene Therapy Program, Boston Children's Dana-Farber Cancer and Blood Disorder Center, Boston, MA 02115, USA.
Danilo PellinGene Therapy Program, Boston Children's Dana-Farber Cancer and Blood Disorder Center, Boston, MA 02115, USA.
Alessandra BiffiDivision of Pediatric Hematology, Oncology and Stem Cell Transplantation, Woman's and Child Health Department, University of Padova, 35128 Padova, Italy.
Dana-Farber/Boston Children's Cancer and Blood Disorders Center · USUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

gene therapyHSPCslentiviral vectorprostaglandin E2transduction enhancer

Identifiers

PMID37920236
PMCPMC10618226
OpenAlexW4387524045

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.